Loans to SanBio, Inc., Allowance for Doubtful Accounts and Debt-to-Equity Conversion
First written in FY2024. . Latest entry: FY2026.
The whole theme swung hardest in 2026: 11 of 18 companies on the "Worse" side.
6 other companies' latest entry also says "Other".
- FY2026Continued decline in balances of loans to affiliated companies and allowances for doubtful accountsAnnual report
「Long-term loans to affiliated companies ¥8,030,360 thousand ¥3,073,200 thousand” “Allowance for doubtful accounts ¥8,847,016 thousand ¥2,931,000 thousand」
Long-term loans to SanBio, Inc. stood at ¥3,073 million and the allowance for doubtful accounts at ¥2,931 million, both down from the previous fiscal year. - FY2025Decline in balances of loans to affiliated companies and allowances for doubtful accountsAnnual report
「Long-term loans to affiliated companies ¥10,402,275 thousand ¥8,030,360 thousand” “Allowance for doubtful accounts ¥11,520,016 thousand ¥8,847,016 thousand」
Long-term loans to SanBio, Inc. stood at ¥8,030 million and the allowance for doubtful accounts at ¥8,847 million, both down from the previous fiscal year. - FY2024First statedAnnual report
「Long-term loans to affiliated companies ¥10,402,275 thousand” “Allowance for doubtful accounts ¥11,520,016 thousand” “The decrease in the allowance for doubtful accounts during the current fiscal year represents the amount reversed in connection with the execution of a debt-to-equity swap with a subsidiary.」
The Company recorded long-term loans to SanBio, Inc. and an allowance for doubtful accounts, and reversed part of the allowance for doubtful accounts during the current fiscal year in connection with a debt-to-equity swap with the subsidiary. The parent company on a standalone basis also recorded an impairment loss on investments in affiliated companies of ¥2,667 million and a provision for doubtful accounts for affiliated companies of ¥2,027 million.